Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD

Clinical trial NCT02847624 · COMPLETED

Trial details

NCT number: NCT02847624
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Status: COMPLETED
Study type: OBSERVATIONAL

Polycystic Kidney, Autosomal Dominant

Start date: 2014-03-24
Primary completion: 2022-09-20
Enrollment: 1802

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.